Processa Pharmaceuticals PCSA
NASDAQ PCSA
$1.74 +0.01 (+0.60%)
As of: Oct 21, 2026 · 10:17 AM EDT

Processa Pharmaceuticals (PCSA) Capital Leases (2024)

Updated

Processa Pharmaceuticals (PCSA) reported Capital Leases of $487.00 for Q4 2024, down 77.5% from the prior quarter.

Analysis

Processa Pharmaceuticals (PCSA) Capital Leases (2024) Analysis & Trends

Dating back to Q1 2024, Processa Pharmaceuticals' Capital Leases record includes 4 quarters.

  • Per Business Quant data, the three quarters before Q4 2024 came in at $2,168 (Q3 2024), $3,817 (Q2 2024) and $6,107 (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn
10 Processa Pharmaceuticals 4.79 Mn -8.96 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 487.00
Sep 30, 2024 2,168.00
Jun 30, 2024 3,817.00
Mar 31, 2024 6,107.00
API Access

Processa Pharmaceuticals Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=PCSA&period=max&api_key=YOUR_API_KEY